Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 50,000 shares at $16.07 ($804K) on 2023-03-20, disclosed to the SEC on 2023-03-22.
Open-market sale of $804k CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2025-09-05 | $1.4M | — | Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |